{
    "nctId": "NCT06011525",
    "briefTitle": "Prevention of Alopecia in Patients With Localised Breast Cancer",
    "officialTitle": "Prevention of Alopecia in Patients With Localised Breast Cancer by Scalp cooLing vs Cooling Mask: a Randomised Controlled Trial With Medico-economic Evaluation",
    "overallStatus": "RECRUITING",
    "conditions": "Chemotherapy-induced Alopecia",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 196,
    "primaryOutcomeMeasure": "Compare the grade of the patient alopecia.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \\>18\n* Female\n* Histologically proven diagnosis of localised, non-metastatic breast cancer\n* Indication for neo-adjuvant or adjuvant anthracycline and taxane chemotherapy (3 EC100 followed by 3 Docetaxel or 3 EC100 plus 12 Paclitaxel); HER-positive status is not a non-inclusion criterion.\n* Patient willing to be photographed to assess IFA\n* Fluency in French\n* Patient affiliated to a social security scheme\n* Signature of informed consent\n\nExclusion Criteria:\n\n* History of neck pain\n* Pre-existing alopecia\n* Participation in another trial\n* Dermatosis of the scalp\n* Contraindication to scalp cooling\n* History of migraines, stroke or hyperthyroidism\n* History of scalp metastases\n* Sensitivity to cold, cold agglutinin disease, cryoglobulinaemia, cryofibrinogenaemia or post-traumatic cold dystrophy.\n* Malignant haemopathies\n* History of chemotherapy treatment\n* Indication for cerebral irradiation\n* Pregnant or breast-feeding patient\n* Raynaud's syndrome",
    "sex": "FEMALE",
    "minimumAge": "18 Months",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}